NeuroSense Therapeutics Warrant
NRSNW
4 hedge funds and large institutions have $17.1K invested in NeuroSense Therapeutics Warrant in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0.06% less ownership
Funds ownership: 0.78% → 0.72% (-0.06%)
32% less capital invested
Capital invested by funds: $25K → $17.1K (-$7.88K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$1.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$2.01K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$713 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$69 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $9.87K | +$1.1K | +6,487 | +11% |
|
|
2
Citadel Advisors
Miami,
Florida
| $3.79K | -$713 | -4,190 | -14% |
|
|
WAM
3
Warberg Asset Management
Winnetka,
Illinois
| $3.43K | -$2.01K | -11,805 | -37% |
|
|
4
UBS Group
Zurich,
Switzerland
| $28 | -$69 | -405 | -67% |
|
NRSNW Hedge Fund Activity: Q3 2024 in Review
4 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in NeuroSense Therapeutics Warrant (NRSNW) for Q3 2024, worth a combined $17.1K — down 32% from $25K a quarter earlier.
Fund positioning in NRSNW was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Clear Street, adding an estimated $1.1K. The largest seller was Warberg Asset Management, cutting an estimated $2.01K.
- 4 institutional investors held NeuroSense Therapeutics Warrant (NRSNW) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $17.1K of NeuroSense Therapeutics Warrant stock for Q3 2024, down 32% quarter-over-quarter.
- 0 funds opened new NeuroSense Therapeutics Warrant positions in Q3 2024 and 0 closed out.
- The largest NeuroSense Therapeutics Warrant buyer in Q3 2024 was Clear Street, an estimated $1.1K added.
- The largest NeuroSense Therapeutics Warrant seller in Q3 2024 was Warberg Asset Management, an estimated $2.01K sold.
Based on aggregated 13F filings for Q3 2024.